Tag:

Colobreathe

Latest Headlines

Latest Headlines

Forest Labs to launch inhaled lung infection drug in Germany

February 29, 2012

Forest Laboratories ($FRX) says it will use Germany to launch the European Union rollout of Colobreathe, its new dry powder inhalation treatment for cystic fibrosis-related lung infections, by...

THE LIBRARY: WEBINAR

Pharmaceutical Development for ADCs: Not as Simple as ABC

| Thursday, May 30 | 2pm ET/ 11am PT | SPONSORED BY: BAXTER BIOPHARMA SOLUTIONS

Formulation, process, and analytical development for ADCs is complex. Join our experts as we discuss ADC structure and function, the development process (including analytical methods, stability, and lyo cyle optimization) and parenteral product development. Register Today!

MORE ITEMS

Press Releases

Featured Jobs

Import/Export Specialist Job
Celgene Corporation - Basking Ridge NJ US
1.Global Pharma Key Opinion Leaders Program/2.Global Pharmaceutical Experts
Korea Health Industry Development Institute -
Quality Control Lead
Infinity Pharmaceuticals - Cambridge MA
Research Associate - Biochemistry
Syros Pharmaceuticals - Watertown Massachusetts
Sr. Manufacturing Process Lead Job
Celgene Corporation - Basking Ridge NJ US

Sponsored Links

Colobreathe

Latest Headlines

Forest Labs to launch inhaled lung infection drug in Germany

THE LIBRARY: WEBINAR

A publication of FierceMarkets

The FierceMarkets Network:

Telecom

Marketing & Retail

Healthcare

Government

Energy

Life Sciences

Enterprise IT

Finance

Colobreathe

Latest Headlines

Forest Labs to launch inhaled lung infection drug in Germany

Join 13,000+ Insiders SIGN UP FOR OUR NEWSLETTER

THE LIBRARY: WEBINAR

A publication of FierceMarkets

The FierceMarkets Network:

Telecom

Marketing & Retail

Healthcare

Government

Energy

Life Sciences

Enterprise IT

Finance